Avandia Overview: Avandia Side Effects and Claims
Get Legal Help Today
Secured with SHA-256 Encryption
UPDATED: Jun 19, 2018
It’s all about you. We want to help you make the right legal decisions.
We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.
Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.
Avandia, generic rosiglitazone maleate, is a drug to treat Type 2 diabetes and is manufactured by the UK-based pharmaceutical giant GlaxoSmithKline (GSK). Type 2 diabetes is the most common form of diabetes, affecting about 18 million Americans. In Type 2 diabetes the body either does not produce enough insulin or does not use insulin properly. This results is high blood sugar levels that can cause problems such as kidney and eye damage. The Avandia claim is that it lowers blood sugar levels by increasing the sensitivity to insulin in peripheral tissue.
Avandia is the top-selling diabetes drug in the world and the second best seller for GSK, after its asthma drug Advair. It’s estimated that Avandia was taken by 1 million Americans in 2006 and generated $3 billion in sales. Avandia was approved by the FDA (Food and Drug Administration) on May 15, 1999 for the treatment of diabetes. There was some controversy about the approval, but the FDA may have wanted to expedite the approval since problems had already arisen with the other diabetes drug then on the market, Pfizer’s Rezulin. Rezulin was removed from the market in 2000 because it caused sometimes fatal liver problems.
Avandia is part of a class of drugs known as PPAR agonists. These drugs activate or suppress dozens of genes, causing complex biologic effects. The effects differ from one PPAR agonist to another, depending on the genes affected.
Avandia hit the headlines on May 21, 2007 when a meta-analysis of 42 studies on the use of Avandia showed a significant increase in the risk of heart attack and other heart problems. See Avandia Information and Warnings for more information. The FDA eventually issued a warning about the study and required GSK to include a black box warning of cardiac side effects and to produce a new prescription guide that included these warnings. Critics claim the FDA should have acted sooner. The agency came under criticism and scrutiny for its handling of the Avandia approval and review. See Avandia Side Effects and Risks
Check out the following articles for more information about Avandia, filing an Avandia lawsuit and finding an Avandia attorney.
- For more information about Avandia side effects, see Avandia Side Effects – Heart Attack and Fractures
- To find out more about the FDA warning, see Avandia Side Effects and Risks
- For more information about Avandia updates, see Avandia Information and Warnings
- If you would like to learn more about Avandia lawsuits, see Avandia Lawsuits, Litigation & Lawyers
- To learn more about Avandia attorneys and how to find one, see Hiring a Avandia Attorney and Lawyer